All posts by imreal

Great Point Partners II Sells Citra Health Solutions to Cedar Gate Technologies


Great Point Partners (“GPP”), a Greenwich-based private investment firm focused exclusively on the health care industry, announced today that it has signed a definitive agreement to sell GPP II portfolio company, Citra Health Solutions (“Citra” or the “Company”), to Cedar Gate Technologies, a portfolio company of GTCR Private Equity. Citra, based in Raleigh, NC is a tech‐enabled software platform that automates and manages complex capitated arrangements for payers and providers. The Company provides a robust technology platform (EZ-SUITE) to support providers and payers managing at‐risk, value‐based arrangements. EZ-SUITE offers eligibility management, utilization management, care management, and administration of complex contractual arrangements including capitation and automated claims.

Adam Dolder, Managing Director at GPP commented, “This successful investment was grounded in our thematic approach in 2014 to capitalize on the changes in the health care system driven by increasing value-based care trends. We were fortunate to recruit Scott Sanner (CEO) and an entirely new team to drive Citra and together, we made the key decision to focus the Company on its software solution and are thrilled with the outcome.”

“When I joined Citra two years ago, I was excited to partner with Great Point because of their health care expertise and track record of success in health care information technology,” Scott Sanner, Chief Executive Officer at Citra, stated.

“Our expertise in proprietarily sourcing add-on acquisitions enabled Citra to make a key acquisition of a highly strategic and complementary technology company, which helped drive significant value,” added Bret Tenenhaus, Senior Vice President at GPP.

“Over the last five years, the Company grew revenue at a 18% rate per year and EBITDA at a 43% rate per year,” said Eddie Hjerpe, Vice President at GPP.

Cain Brothers and Falcon Capital Partners served as financial advisors to Citra and McDermott Will & Emery served as legal counsel to Citra.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm, currently with approximately $2.0 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $307 million in committed capital) and public (BioMedical Value Fund family, approximately $1.5 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical and medical device services and supplies, alternate site care, and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or http://www.gppfunds.com.

About Citra Health Solutions

Citra provides a one-contract, connected solution for clinical, financial and administrative requirements. Solving for the needs of providers, payers, health systems and employers in the transition to value-based care, Citra empowers clients with proven technology, population health, analytics, care management, and administrative services to lower the cost of care and improve quality. Citra currently serves 6 of the top 7 Health Plans, 7 Fortune 500 Companies, 50+ IPAs and MSOs managing commercial, Medicare and Medicaid populations, and 100+ Provider Groups, Hospitals, Universities and Integrated Delivery Networks throughout the United States and in Puerto Rico.

Share article on social media or email:

NeoTract Designates Dr. Tarek Pacha as UroLift® Center of Excellence


News Image

“We are pleased to recognize Dr. Tarek Pacha as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Tarek Pacha, D.O., Memorial Heathcare in Owosso, MI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Pacha has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Tarek Pacha as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Zivra Announces Strategic Partnership With Eggplant to Resell and Deliver High-Quality Test Automation (TestOps) Solutions and Services in the US and Latin America


zivra devsecops test ops test automation

Zivra & Eggplant

Eggplant provides a future-proof platform that combines testing, monitoring, and the measurement of digital success. It applies artificial intelligence and machine learning to assist in the delivery of DevSecOps at scale.” said, Arthur Alvarez, Director of Sales and Alliances at Zivra.

Zivra, a leading DevSecOps global strategic consulting and solutions integration company today announced a strategic partnership with Eggplant, the intelligent automation specialist, to resell and provide services around Eggplant’s intelligent testing and monitoring automation products as part of Zivra’s DevSecOps portfolio of offerings.

Headquartered in Chicago, Zivra provides premier consulting services and solutions that enable Enterprises to accelerate their digital transformation through a proprietary DevSecOps Framework that focuses on automation and modernization, security, and Cloud transformation. A partnership with Eggplant enables Zivra to further expand its portfolio of best-of-breed DevSecOps solutions to help companies as they evolve their automation initiatives to include test automation, a key component of what Zivra defines as TestOps. TestOps is a term derived from two technology functions: Testing and Operations, similar to how DevOps was coined from Development and Operations, which refers to a more evolved version of traditional and manual testing.

The move comes as a response to the growing demand from organizations of all sizes and across many different market segments seeking to move from predominantly manual to automated quality assurance as part of their overall digital transformation strategy. With faster release cycles and increased delivery speed, manual testing or partial automation to test functionality is no longer sufficient. A future-proof test automation strategy needs to be an integral part of any DevSecOps transformation and Eggplant provides an innovative intelligent automation platform to support such a strategy.

“Many of our clients have begun their DevSecOps transformation journey and have implemented some level of CI/CD automation. They are looking at other areas to automate, and manual testing is naturally another automation challenge to tackle. Eggplant provides a future-proof platform that combines testing, monitoring, and the measurement of digital success. It applies artificial intelligence and machine learning to assist in the delivery of DevSecOps at scale.” said, Arthur Alvarez, Director of Sales and Alliances at Zivra. “Eggplant’s solutions fit very well within our DevSecOps Enterprise Framework and address our clients’ needs.”

“Zivra is a recognized leader in supporting and helping organizations deliver on the promise of DevSecOps,” said Michael Eckhoff, Vice President, Sales, Eggplant. “Intelligent test automation is critical if organizations are to accelerate the pace of digital transformation. Our AI-driven platform automates the testing lifecycle so that every organization can benefit from continuous intelligent testing.”

About Zivra

Zivra provides high-end advisory services and industry insight with the goal of helping enterprises develop and implement their Digital Transformation strategy. Our mission is to promote strategic initiatives around Development Operations, Cloud provisioning, security, and custom Agile development that increase the effectiveness of a technology organization throughout their software development lifecycle. Zivra is headquartered in Chicago with offices in Texas, Mexico, Argentina, and Brazil. Learn more at zivra.com.

About Eggplant

Eggplant, the fastest growing automation provider and a portfolio company of The Carlyle Group, provides user-centric, intelligent testing and performance solutions designed to optimize the digital experience, delight customers, and drive business success. Only Eggplant enables organizations to test, monitor, analyze, and report on the quality and responsiveness of software applications across different interfaces, platforms, browsers, and devices, including mobile, IoT, desktop, and mainframe. Learn more at  eggplantsoftware.com.

Share article on social media or email:

Orfit Aerial Couch Top for Proton Therapy Validated by Mevion Medical Systems


“Mevion is committed to providing customizable and complementary immobilization products to our customers and we are excited to partner with Orfit to add the Aerial Couch Top and accessories to our proton therapy systems,” said Ying Xiong, vice president of product management at Mevion Medical Systems.

The Aerial Couch Top combines precise and reproducible immobilization with homogeneity over the entire treatment area. With no rails or other obstructions below the extension, this recently US FDA cleared couch top minimizes the air gap, improving penumbra and plan quality. Aerial extensions are available for extracranial treatment and brain, head, and neck treatments when used with Orfit HP PRO masks. The use of 3-points single layer HP PRO masks can reduce target margins to 1 mm.

“The design of the Aerial is in line with the highest technical and safety standards, without being overly complex, so that it helps assure the best possible clinical outcome for patients. This couch top perfectly pairs with advanced proton therapy systems, such as MEVION S250i,” states Emilie Cuypers, product manager radiation oncology at Orfit.

Together, we are pleased to make this entirely new couch top available as of September 2020 to current and future Mevion operated proton therapy centers.

Share article on social media or email:

Publication Geared to Helping Navigate Complicated Appeals Process


News Image

“A primary goal of The Health Insurance Appeals Guide is to empower individuals to better understand their rights to file a health insurance appeal”, notes Mary Covington, President, Denials Management and co-author.

Denials Management, Inc. has just published The Health Insurance Appeals Guide to inform consumers and treating providers on the key steps when filing appeals for denials of mental health and substance use disorder (MH/SUD) treatment services. It was written by leading health insurance experts to help educate individuals about their appeal rights and explain the steps in the appeals process. Complimentary copies of the Guide can be downloaded here.

“A primary goal of The Health Insurance Appeals Guide is to empower individuals to better understand their rights to file a health insurance appeal,” notes Mary Covington, President, Denials Management and co-author. “Whether the individual is a patient, provider, family member, caregiver, or advocate, our shared health care goal is to get the right care to the right patient at the right time. Unfortunately, this is easier said than done. The health insurance system in the United States is complex and confusing. Individuals are often denied coverage by their insurance companies for needed treatment, even though, in most cases, insurers have a contractual and regulatory responsibility to cover and reimburse for evidence-based care that improves a patient’s clinical outcome.”

“Through a system of managed care, health plans can make ‘medical necessity’ or other types of coverage decisions that lead to denials. Sometimes these decisions are made for the right reasons—and prevent patients from receiving dangerous or unnecessary care—but, far too often, these decisions are made with subjective reasoning,” adds Garry Carneal, JD, MA, President and CEO, Schooner Strategies and co-author. “In these cases, patients are left without access to care or are stuck with medical bills they often cannot afford. Therefore, this Guide serves as an invaluable resource to help consumers and others navigate the appeals process.”

“Recognizing the importance of health care decisions in the lives of their constituents, federal and state regulators created a health insurance appeals system to provide an opportunity for people to challenge denials. The process of questioning an insurance company’s decision, or lack thereof, related to an insured’s health care needs has come to be known as the ‘insurance appeals process,’” remarks Justin Eckman, Director of Client Operations, Denials Management and co-author. “It is this process that the Guide seeks to explain.”

The publication is made up of the following sections to help consumers understand the pathway to file a health insurance appeal after a denial of care:

-Definitions. Part I includes a list of key acronyms and defines commonly used insurance and appeals terminology.

-What is health insurance? Part II offers important background information about health insurance and helps individuals determine what type of health plan they have. This information is necessary to understand before filing an insurance appeal because the plan type will determine what appeal options a patient has, as well as the regulatory bodies charged with overseeing the health insurer and maintaining the integrity of the appeals process.

-What should individuals know before filing an appeal? Part III contains information about the administrative and clinical appeals process. The Guide explains the different levels of appeals, as well as the ways in which insurance denials and appeals are broadly categorized and handled. Understanding the different types of denials and appeals procedures can help individuals better understand how the process works and draft a more effective appeal.

-How does mental health parity affect appeals? Part IV explores the landmark Mental Health Parity and Addictions Equity Act of 2008 (MHPAEA), also known as the Federal Parity Law, and explains its significance concerning appeals. The history of the Federal Parity Law and related efforts are discussed, as well as the many ways in which insurance companies have historically failed to fully comply with the law. This section also explains how to assert and prove a parity violation, while leveraging the MPHAEA in appeal letters.

-Preparing an appeal – What’s next? Part V focuses on best practices for drafting an appeal letter and provides appeal advice for the denial classifications identified in Part III of the booklet.

-Final thoughts. Part VI offers some final thoughts on the health insurance appeals process.

-Resources and FAQs. Parts VII and VIII of the booklet provide important resources for appeal writers, including lists of frequently asked questions (FAQs) and additional resources. For consumers who need additional help regarding a mental health parity violation, check out http://www.parityregistry.org.

This publication was sponsored in part by Schooner Strategies.

                                                                             # # #

About Denials Management, Inc. – http://www.fixmyclaim.com

Facing medical, behavioral health, or substance abuse issues can be emotionally challenging and financially stressful for families. Similarly, we understand that providers must focus on the treatment of their patients rather than navigating through complicated utilization review, claims, and appeal processes. Since 1990, Denials Management, Inc. has been partnering with families and providers to assist in resolving the specific insurance problems they are facing. Our experienced medical insurance advocates offer a variety of services, such as claims management, fighting insurance denials, and much more. For more information Denials Management, visit http://www.fixmyclaim.com or email us at intake@denialsmgt.com.

Share article on social media or email:

Dr. Philip Paden, M.D. Nature’s Tears® EyeMist® Immunity Protector on Sharon Kleyne VoiceAmerica Apple iTunes


Sharon Kleyne, Founder of Bio Logic Aqua® Research

Sharon Kleyne, Founder of Bio Logic Aqua® Research

Air Date: 22 June 2020

Guests: Dr. Philip Paden, M.D., Ophthalmologist, Medford, Oregon

https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist

“Eyes are our number one sensory input,” says Philip Paden, M.D., on Sharon Kleyne Talk Radio VoiceAmerica World Talk Radio & Apple iTunes. “Being able to see clearly is being able to receive information you need to proceed with life.” Paden recommends Nature’s Tears® EyeMist® to patients for immunity strengthening protection of the eyes.

Paden began his professional life teaching chemistry for ten years at Cornell University. After graduating from the Albert Einstein College of Medicine if Yeshiva University in 1982 and serving his internship in Portland, Oregon, Paden has practiced ophthalmology in Medford, Oregon where he says the number one complaint he hears from patients is “uncomfortable eyes. If your eyes are uncomfortable,” says Paden, “you are unhappy and not performing at your best.”

In her commentary, internationally respected water technology researcher and host Kleyne, who is also founder of Bio Logic Aqua® Research Water Life Science®, declares that “water is the primary life of earth” and that we all live with the water vapor in the atmosphere. Kleyne also points out that “dry eye is over-evaporation of the eye’s tear film. There are no two eyes alike, no two fingerprints alike and no two skins alike.”

Kleyne teaches immunity strengthening and protection education and also that there is only one dry eye product in the world, Nature’s Tears® EyeMist®, that is 100 percent Trade Secret water and naturally pH balanced without formulating it. “The pH balance is what gives the immunity strengthening protection to the eye.” Noting that Paden is one of the authors of her educational animation of the tear film, which shocked so many viewers, Kleyne asks him to teach the audience about the tear film.

“The surface of the eye,” Paden begins, “is the tear film. The number one role of the tear film is to fill the microscopic bumps in the cornea to give you an optical surface that allows very precise vision. The tear film,” Paden continues, “requires three layers in order to stay on the cornea and not run down and off the eye. There’s a mucous layer on top of that, and an aqueous layer that is almost 100 percent water.”

Paden also teaches that “there is an extremely thin surface on the tear film which consists of a single layer of lipids or fats. It is there to slow down evaporation. This area,” adds Paden, “is full of microorganisms. The tear film is actually an army of antibody molecules. If the eye dehydrates, the antibody molecules don’t work as well. Nature’s Tears® EyeMist® is the only tear supplement that is pure water delivered to the eye as a micron-size mist.” Paden says that other dry eye products flood the eye, washing away the molecular antibodies needed for immunity strengthening protection. When Kleyne asks about the actual size of a micron, Paden explains that a micron is a millionth of a meter, much less than a millimeter.

“Nature’s Tears® EyeMist®,” says Paden, “returns the tear film to its normal osmolarity and thickness. Not a single dry eye product on the planet, other than Nature’s Tears® EyeMist®, restores the tear film.”

LISTEN to the internationally syndicated The Power of Water® & Your Health sponsored by Nature’s Tears® EyeMist®, naturally pH balanced water technology for acid mantel protection, on VoiceAmerica World Talk Radio & Apple iTunes with producer and host Sharon Kleyne and program director Rose Hong of Global Dragon TV. This program features ophthalmologist Philip Paden, M.D.

Follow this link: https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist

Some recent programs feature:

Kevin Kearns & Steven Aithwaite

https://www.voiceamerica.com/episode/124035/earths-human-mission-a-healthier-planet

Mary Carolyn, Nutritionist https://www.voiceamerica.com/episode/123934/natural-immune-boosters

Kevin Kearns & Brandon Foster https://www.voiceamerica.com/episode/123823/strengthening-childrens-immune-system-through-fitness

Dr. Gerald Pollack, Ph.D. https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water

Kevin Kearns & Diana Healy https://www.voiceamerica.com/episode/123560/how-to-stay-active-during-the-pandemiclockdown

Dr. Gerald Pollack, Ph.D. https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water

If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution® technology Nature’s Tears® EyeMist®, sponsor of Sharon Kleyne’s talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

Share article on social media or email:

MyVictory Launches On-Demand Fitness App for Cancer Patients Built by BeCurious Studio


BeCurious Studio LLC was named as a Best-In-Class provider by leading industry analysts Top App Developers & DesignRush following the launch a recent project. BeCurious Studio, the rule breaking web/app development hub, completed work on the first comprehensive exercise/community platform for cancer survivors.

Commissioned by MyVictory Inc, the platform delivers a seamless, individualized healthcare experience encompassing exercise planning, live video instruction, social community, personal goal targeting, and one-on-one consultations.

Working closely with MyVictory’s health and marketing specialists, the BeCurious team applied their rigorously tested and proven process of Discovery, Design, and Development & Testing to methodically identify and build each of the many interlocking application components. MyVictory’s input and review was incorporated at every step of the process in accordance with the BeCurious method of transparent development.

“This is exactly the type of project we love,” said BeCurious founder Stanley Vaganov. “It was complex from a design/engineering/behavioral point of view, it has global appeal, and most importantly it is a great and important cause.”

One of the biggest development challenges in building the application was to meet the wide and varying exercise needs of the cancer survivor community. Additionally, the platform needed to provide flexibility and customization for both users and instructors.

During discovery, the project team created a detailed matrix of user profiles and a corresponding table of necessary key ingredients including live streaming and recorded instruction, user and administration dashboards, a cancer resource center, and a goal tracker. The discovery also revealed the strong need for the platform to be:


  • Community oriented
  • Mobile & tablet friendly
  • HIPPA & privacy compliant
  • Capable of multi-memberships
  • Social interaction enabled

BeCurious Studio LLC is a full service, award-winning design and development studio. The company has extensive experience in health, legal, education, fashion, and e-commerce industries. Established in New York City, the company was an early adopter of a distributed workforce model ensuring its uninterrupted ability to serve clients during the current COVID-19 crisis. Agency specializes in web and mobile design and development and have won numerous awards and recognitions for their work. The key difference is their extensive discovery process that focuses on human centered approach in identifying solutions and solving problems.

For inquiries about new projects, please visit us at http://www.becurious.co

Share article on social media or email:

Pivot Point Consulting Expands Telehealth Services & Continues Pro Bono FCC Telehealth Program Guidance & Telehealth Strategy Workshops


Laura Kreofsky, Advisory VP, leads Pivot Point Consulting telehealth services

Success in today’s fast-moving telehealth market requires a blend of competitive and environmental intelligence, technology, workflow and revenue cycle readiness and intentional focus on the patient experience.

Pivot Point Consulting, a national healthcare IT consulting leader and the 2020 Best in KLAS Overall IT Services Firm, expanded its telehealth services to provide end-to-end solutions from strategy to platform selection to implementation.

Led by seasoned telehealth expert and a Consulting Magazine “2020 Women Leaders in Technology” award winner, Laura Kreofsky, Advisory VP, Pivot Point Consulting’s telehealth specialists help healthcare providers strategically grow virtual care programs and optimize telehealth platforms. They bring focused expertise in telehealth regulations, experience in platform, device and third-party application selecting, implementation and optimization and best practices in telehealth support.

“Success in today’s fast-moving telehealth market requires a blend of competitive and environmental intelligence, technology, workflow and revenue cycle readiness and intentional focus on the patient experience,” says Kreofsky.

“Whether you’re new to telehealth or if you have telehealth services to take to the next level, we bring market insights and best practices, disciplined methodology and specialists experienced in setting and executing on strategic telehealth goals.”

As part of the telehealth service portfolio, Pivot Point Consulting continues to provide pro bono assistance to providers and healthcare organizations on the FCC COVID-19 telehealth funding program and offer complimentary telehealth strategy workshops to provider organizations.

“We have always invested in telehealth, but now we’re doubling down to keep pace with the needs of today’s rapidly changing market,” says Rachel Marano, Co-Founder and Managing Partner.

About Pivot Point Consulting

Pivot Point Consulting, 2020 Best in KLAS: Overall IT Services Firm, enables healthcare organizations to realize the most value from their technology and data through our Advisory, Implementation, Optimization, Managed Services and Talent Solutions. We work with provider and payer organizations and have 450+ employees serving over 100 clients across the U.S. Pivot Point Consulting has earned many industry and workplace quality awards including: 

Best in KLAS: Overall IT Services Firm (2020) , Top Three Best in KLAS for HIT Implementation and Support (2015, 2016, 2017, 2018, 2019) , Highest Rated Vendor in KLAS Implementation Services in the Select Category (2017) , #1 in KLAS for Epic Consulting in the Select Category (2016) , #9 in Modern Healthcare’s Best Places to Work (2016)  

Practices: Epic®, Community Connect®, Cerner®, Siemens®, Allscripts®, MEDITECH®, McKesson®, Centricity®, eClinicalWorks®, NextGen® CPSI®, MEDHOST®, athenahealth®, Greenway®, Workday®, Lawson/Infor®, Peoplesoft®, SAP®, Kronos® and Facets®.  

For more information, visit us at pivotpointconsulting.com.

Share article on social media or email:

Billon Group wins Innovate UK grant to develop COVID-19 training and immunity certificates on distributed ledger


Against the backdrop of ongoing social distancing, Billon’s ability to make documents available for trusted verification without the need for personal contact could reduce administrative burdens and overcome obstacles to re-employment.

Billon Group received a £50,000 grant in the Fast Start Competition by Innovate UK to build a distributed ledger platform to store COVID-19 related certificates to support workers’ safe return to the workplace. By the end of August, Billon will provide a fully functioning prototype for publishing, sharing and verifying a wide array of workplace training or medical test documents as a back-end system for any company or governmental issuer of certificates.

With businesses and governments around the world struggling to limit the health and economic impact of the pandemic, the solution addresses three key challenges:

  • How to prove who has completed training or has a test result (including linking multiple certificates to an identity),
  • How to ensure the privacy of individual’s personal health and work records, and
  • How to provide proof in a hands-free or reduced contact manner.

David Putts, Chief Growth Officer of Billon, comments, “Billon wants to do its part to get employees back to work safely and for the economy to stay open. With this project, we want to encourage companies and health organisations to provide proper training and testing and to take advantage of new blockchain and identity management technology to equip people to prove they have an authentic certificate — while hiding private data from those that would exploit it. We need solutions that protect people and their data. This project will deliver such a solution.”

The prototype aims to be a plug-and-play solution that augments any existing issuer of a certificate by providing the distributed ledger innovation behind the scenes. Companies will be able to connect their existing systems via APIs, so there would be minimal integration. Users would be able to control their certificates on their mobile phones and show them, when needed, in a user-friendly way.

Public bodies, such as health organizations, could certify essential standards for returning to work — for example, that a worker has completed specialized training or has medically established COVID-19 immunity. Companies who train their workers, such as airlines, can issue certificates. Issuers of other professional, vocational or education certificates, diplomas, licenses, certified statements and other documents can also make use of Billon’s distributed ledger technology to ensure workplace safety. The goal is to allow certificate holders to safely go back to work while businesses have certainty that employees undertook required training or tests.

It’s an approach similar to that taken by other Billon clients, including the Polish credit reporting bureau BIK, energy company Tauron, and the Polish chapter of IEEE, which all use Billon’s trusted document management system to store and publish high-value documents on-chain.

While global debate continues over the privacy implications of many other approaches to pandemic tracking, the Billon solution uniquely applies distributed ledger (blockchain) technology to deliver immutable, tamper-free solutions designed to comply with GDPR and other privacy regulations. Certificates are linked to the identity of the user, encrypted with keys that only the user and the issuer can use so that other companies using the platform, or even the network administrator, cannot see any private data.

Another unique trait of the approach is that document validity can be programmed for a specific duration or other guidelines. The ledger ensures that each certificate will be automatically updated as the pandemic situation evolves.

Against the backdrop of ongoing social distancing, Billon’s ability to make documents available for trusted verification without the need for personal contact could reduce administrative burdens and overcome obstacles to re-employment. The ability to ensure quick and trusted verification is also key to providing a safe environment for everyone, limiting the spread of the virus.

Billon is one of 800 projects selected from more than 8,600 applications to the Fast Start Competition launched in April by Innovate UK. Grants provide technology and research-focused businesses resources to develop new ways to work; to build resilience in industries such as delivery services, food manufacturing, retail and transport; and to support people at home during the coronavirus outbreak. Other projects to benefit from the funding include virtual reality training platforms for surgeons, virtual farmers’ markets and other innovations born of the coronavirus pandemic.

Dr. Ian Campbell, Executive Chair, Innovate UK, comments, “Businesses from all over the UK have answered our call rapidly to meet the challenges we face today and in the future through the power of innovation. The ideas we have seen can truly make a significant impact on society, improve the lives of individuals and enable businesses to prosper in challenging circumstances.”

About Billon

Billon created the first enterprise DLT system which unifies national currency transactions, document management, and identity management into a single architecture. We solved the challenge to allow banks to use blockchain for national currency applications, and we also encrypt documents and data on-chain, unleashing the transformational capacities of blockchain technologies in the regulated world. Billon’s underlying protocol was designed for high-performance and to support tangible business results in the areas of Accounts & Transactions, Trusted Documents, and Identity & Data Sharing.

Billon Group Ltd. was founded in the UK in 2015, following several years of R&D in Poland. Its unique DLT protocol has been supported by many R&D grants, including the EU Horizon 2020 program. Billon is licensed to issue electronic money by regulators in the UK and Poland.

Billon recently completed its Series A financing, and its growing client list includes leading companies such as FIS, Raiffeisen Bank International and BIK (the Polish credit office). Billon has offices in London and Warsaw. For more information, visit http://www.billongroup.com.

About Innovate UK

Innovate UK drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas. We connect businesses to the partners, customers and investors that can help them turn ideas into commercially successful products and services and business growth. We fund business and research collaborations to accelerate innovation and drive business investment into R&D. Our support is available to businesses across all economic sectors, value chains and UK regions. Innovate UK is part of UK Research and Innovation. For more information visit http://www.innovateuk.ukri.org

Share article on social media or email:

R3 Medical Training Announces Healthcare Sales & Marketing Course Now Enrolling in August for Several Locations


healthcare marketing course

Two Day Healthcare Sales & Marketing Course (888) 998-6343

I’ll be teaching attendees how to cost effectively obtain patients through online efforts. With my practice we obtained 80% of our patients through the web, and we did it at half the national average cost for patient acquisition. The techniques work amazingly well

R3 Medical Training announced today it is now enrolling for its new Healthcare Sales and Marketing Course taking place in August at several locations. The first course is August 6-7, 2020 in San Diego and the second is August 20-21, 2020 in Nashville. In addition, the course is being offered as a Virtual Live Stream option.

The two day agenda for each course is identical, covering a comprehensive set of sales and marketing topics. This includes presentations on obtaining patients through referrals, online efforts, Facebook, YouTube, radio, tv, billboard and other efforts. In addition, the course will teach attendees how to differentiate their practice and overcome objections for lead conversion.

With over 70% of prospective patients using the internet to make healthcare decisions, it is very important that providers and their marketers be adept at online marketing techniques for patient acquisition. Presenter David Greene, MD, MBA, has written two books on Healthcare Internet Marketing and teaches that portion of the course.

According to Dr. David Greene, “I’ll be teaching attendees how to cost effectively obtain patients through online efforts. With my practice we obtained 80% of our patients through the web, and we did it at half the national average cost for patient acquisition. The techniques work amazingly well!”

For both of the San Diego and Nashville courses, people may participate either in person or virtually with a live stream. The courses include twelve presentations, and each attendee will also receive a free copy of Dr. Greene’s latest Healthcare Internet Marketing book along with a One on One Coaching Session as well.

To sign up for the Healthcare Sales and Marketing Course, simply call (888) 998-6343 or visit https://r3medicaltraining.com/events/healthcare-sales-marketing-course/ for more information.

Share article on social media or email: